{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:39:25Z","timestamp":1770968365812,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T00:00:00Z","timestamp":1352332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11095-012-0916-0","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T12:24:54Z","timestamp":1352291094000},"page":"606-615","source":"Crossref","is-referenced-by-count":9,"title":["Extraction of PLGA-Microencapsulated Proteins Using a Two-Immiscible Liquid Phases System Containing Surfactants"],"prefix":"10.1007","volume":"30","author":[{"given":"Vivian","family":"Saez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liurdis","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymersy","family":"Aldana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli\u00e1n","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Peniche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Paez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,8]]},"reference":[{"issue":"6","key":"916_CR1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/jps.22054","volume":"99","author":"DS Pisal","year":"2010","unstructured":"Pisal DS, Kosloski MP, Balu-Iyer SV. Delivery of therapeutic proteins. J Pharm Sci. 2010;99(6):2557\u201375.","journal-title":"J Pharm Sci"},{"issue":"2","key":"916_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2010.05.011","volume":"146","author":"M Ye","year":"2010","unstructured":"Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release. 2010;146(2):241\u201360.","journal-title":"J Control Release"},{"issue":"3","key":"916_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejpb.2004.10.006","volume":"59","author":"U Bilati","year":"2005","unstructured":"Bilati U, All\u00e9mann E, Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm. 2005;59(3):375\u201388.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"916_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/71875","volume":"18","author":"K Fu","year":"2000","unstructured":"Fu K, Klibanov AM, Langer R. Protein stability in controlled-release systems. Nat Biotechnol. 2000;18(1):24\u20135.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"916_CR5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-3659(03)00194-9","volume":"90","author":"VR Sinha","year":"2003","unstructured":"Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90(3):261\u201380.","journal-title":"J Control Release"},{"issue":"7","key":"916_CR6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nm0796-795","volume":"2","author":"OL Johnson","year":"1996","unstructured":"Johnson OL, Cleland JL, Lee HJ, Charnis M, Duenas E, Jaworowicz W, Shepard D, Shahzamani A, Jones AJ, Putney SD. A month-long effect from a single injection of microencapsulated human growth hormone. Nat Med. 1996;2(7):795\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"916_CR7","first-page":"31","volume":"25","author":"V Saez","year":"2008","unstructured":"Saez V, Ramon JA, Aldana R, P\u00e9rez D, Hardy E. Microencapsulation of recombinant interferon \u03b1-2b into poly (D, L-lactide-co-glycolide) microspheres. Biotecnol Apl. 2008;25(1):31\u201341.","journal-title":"Biotecnol Apl"},{"issue":"6","key":"916_CR8","first-page":"661","volume":"65","author":"HK Kim","year":"1999","unstructured":"Kim HK, Park TG. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotechnol Bioeng. 1999;65(6):661\u20137.","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"916_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2004.04.020","volume":"98","author":"HK Kim","year":"2004","unstructured":"Kim HK, Park TG. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D, L-lactic-co-glycolic acid) microspheres: morphological effect on protein release. J Control Release. 2004;98(1):115\u201325.","journal-title":"J Control Release"},{"issue":"6","key":"916_CR10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/02652049809008253","volume":"15","author":"G Crotts","year":"1998","unstructured":"Crotts G, Park TG. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencapsul. 1998;15(6):699\u2013713.","journal-title":"J Microencapsul"},{"issue":"2","key":"916_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0939-6411(00)00099-0","volume":"50","author":"HB Ravivarapu","year":"2000","unstructured":"Ravivarapu HB, Burton K, DeLuca PP. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Eur J Pharm Biopharm. 2000;50(2):263\u201370.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"916_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0168-3659(01)00403-5","volume":"75","author":"BH Woo","year":"2001","unstructured":"Woo BH, Kostanski JW, Gebrekidan S, Dani BA, Thanoo BC, DeLuca PP. Preparation, characterization and in vivo evaluation of 120-day poly(D, L-lactide) leuprolide microspheres. J Control Release. 2001;75(3):307\u201315.","journal-title":"J Control Release"},{"issue":"2","key":"916_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-3659(98)00147-3","volume":"58","author":"XM Deng","year":"1999","unstructured":"Deng XM, Li XH, Yuan ML, Xiong CD, Huang ZT, Jia WX, Zhan YH. Optimization of preparative conditions for poly-DL-lactide-polyethylene glycol microspheres with entrapped vibrio cholera antigens. J Control Release. 1999;58(2):123\u201331.","journal-title":"J Control Release"},{"issue":"2","key":"916_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-5173(99)00178-7","volume":"185","author":"A S\u00e1nchez","year":"1999","unstructured":"S\u00e1nchez A, Villamayor B, Guo Y, McIver J, Alonso MJ. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int J Pharm. 1999;185(2):255\u201366.","journal-title":"Int J Pharm"},{"issue":"6\u20137","key":"916_CR15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0264-410X(96)00233-2","volume":"15","author":"RK Gupta","year":"1997","unstructured":"Gupta RK, Chang AC, Griffin P, Rivera R, Guo YY, Siber GR. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. Vaccine. 1997;15(6\u20137):672\u20138.","journal-title":"Vaccine"},{"issue":"12","key":"916_CR16","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/js9900654","volume":"88","author":"H Sah","year":"1999","unstructured":"Sah H. Protein behavior at the water\/methylene chloride interface. J Pharm Sci. 1999;88(12):1320\u20135.","journal-title":"J Pharm Sci"},{"issue":"3","key":"916_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0939-6411(98)00011-3","volume":"45","author":"D Blanco","year":"1998","unstructured":"Blanco D, Alonso MJ. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm. 1998;45(3):285\u201394.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"916_CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-3659(96)01511-8","volume":"44","author":"G Crotts","year":"1997","unstructured":"Crotts G, Park TG. Stability and release of bovine serum albumin encapsulated within poly(D, L-lactide-co-glycolide) microparticles. J Control Release. 1997;44(2):123\u201334.","journal-title":"J Control Release"},{"issue":"5","key":"916_CR19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/gut.47.5.622","volume":"47","author":"DP Calnan","year":"2000","unstructured":"Calnan DP, Fagbemi A, Berlanga-Acosta J, Marchbank T, Sizer T, Lakhoo K, Edwards A, Playford R. Potency and stability of C truncated human epidermal growth factor. Gut. 2000;47(5):622\u20137.","journal-title":"Gut"},{"issue":"4","key":"916_CR20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJMoa013136","volume":"349","author":"A Sinha","year":"2003","unstructured":"Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med. 2003;349(4):350\u20137.","journal-title":"N Engl J Med"},{"issue":"5","key":"916_CR21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1023\/A:1008945125730","volume":"13","author":"H Santana","year":"1999","unstructured":"Santana H, Espino Y, Franco A, Furrazola G, Hardy E. A sandwich-type enzyme-linked immunosorbent assay for the analysis of recombinant human interferon \u03b1-2b. Biotech Tech. 1999;13(5):341\u20136.","journal-title":"Biotech Tech"},{"issue":"1","key":"916_CR22","first-page":"34","volume":"11","author":"J Ferrero","year":"1994","unstructured":"Ferrero J, Ochagav\u00eda ME, Aguilera A, L\u00f3pez-Saura P. Interferon antiviral activity titration using the \u201cSUMA\u201d device system. Biotecnol Apl. 1994;11(1):34\u201342.","journal-title":"Biotecnol Apl"},{"issue":"5259","key":"916_CR23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680\u20135.","journal-title":"Nature"},{"issue":"1","key":"916_CR24","first-page":"78","volume":"11","author":"M Mart\u00ednez","year":"1994","unstructured":"Mart\u00ednez M, Curr\u00e1s T, P\u00e9rez E, Acosta A, Rojas I, Almaz\u00e1n M, Moya G, P\u00e9rez LC. Control anal\u00edtico y especificaciones de calidad del factor de crecimiento epid\u00e9rmico humano recombinante usado Como materia prima activa en formulaciones farmac\u00e9uticas. Biotecnol Apl. 1994;11(1):78\u201382.","journal-title":"Biotecnol Apl"},{"issue":"1\u20132","key":"916_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpharm.2007.11.012","volume":"350","author":"A Giteau","year":"2008","unstructured":"Giteau A, Venier-Julienne MC, Aubert-Pou\u00ebssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm. 2008;350(1\u20132):14\u201326.","journal-title":"Int J Pharm"},{"issue":"1\u20133","key":"916_CR26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(01)00533-8","volume":"79","author":"G Jiang","year":"2002","unstructured":"Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D, L-lactide-co-glycolide) microspheres. J Control Release. 2002;79(1\u20133):137\u201345.","journal-title":"J Control Release"},{"issue":"1","key":"916_CR27","first-page":"32","volume":"6","author":"FM Freyre","year":"1989","unstructured":"Freyre FM, V\u00e1zquez J, Duarte C, Ferr\u00e1 E, L\u00f3pez I, Arteaga N. Anticuerpos monoclonales que reconocen los factores de crecimiento epid\u00e9rmico humano y murino. Interfer\u00f3n y Biotecnolog\u00eda. 1989;6(1):32\u201346.","journal-title":"Interfer\u00f3n y Biotecnolog\u00eda"},{"issue":"3","key":"916_CR28","first-page":"203","volume":"22","author":"Y Puchades","year":"2005","unstructured":"Puchades Y, Ojalvo AG, Garc\u00eda Y, Chinea G, Ger\u00f3nimo H, Vispo NS. Identification of peptide mimics of the epitope recognized by CB-EGF1, a monoclonal antibody EGF specific. Biotecnol Apl. 2005;22(3):203\u20136.","journal-title":"Biotecnol Apl"},{"issue":"5","key":"916_CR29","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/jps.21544","volume":"98","author":"J Emami","year":"2009","unstructured":"Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A. A novel approach to prepare insulin-loaded poly (lactic-Co-glycolic acid) microcapsules and the protein stability study. J Pharm Sci. 2009;98(5):1712\u201331.","journal-title":"J Pharm Sci"},{"issue":"11","key":"916_CR30","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1023\/A:1013090700443","volume":"18","author":"BH Woo","year":"2001","unstructured":"Woo BH, Jiang G, Jo YW, DeLuca PP. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res. 2001;18(11):1600\u20136.","journal-title":"Pharm Res"},{"issue":"1","key":"916_CR31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jbm.b.31091","volume":"87","author":"S Zhou","year":"2008","unstructured":"Zhou S, Sun J, Sun L, Dai Y, Liu L, Li X, Wang J, Weng J, Jia W, Zhang Z. Preparation and characterization of interferon-loaded magnetic biodegradable microspheres. J Biomed Mater Res B Appl Biomater. 2008;87(1):189\u201396.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"1","key":"916_CR32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/02652040902749061","volume":"27","author":"S Briancon","year":"2010","unstructured":"Al-Haushey L, Bolzinger MA, Fessi H, Briancon S. RhEGF microsphere formulation and in vitro skin evaluation. J Microencapsul. 2010;27(1):14\u201324.","journal-title":"J Microencapsul"},{"key":"916_CR33","first-page":"23","volume-title":"The interferon system","author":"G Bodo","year":"1986","unstructured":"Bodo G, Maurer-Fogy I. Characterization of different molecular species in affinity purified recombinant human interferon alpha 2. In: Dianzani F, Rossi GB, editors. The interferon system, vol. 24. New York: Raven; 1986. p. 23\u20137."},{"issue":"37","key":"916_CR34","doi-asserted-by":"crossref","first-page":"34913","DOI":"10.1074\/jbc.M102874200","volume":"276","author":"HS Lu","year":"2001","unstructured":"Lu HS, Chai JJ, Li M, Huang BR, He CH, Bi RC. Crystal structure of human epidermal growth factor and its dimerization. J Biol Chem. 2001;276(37):34913\u20137.","journal-title":"J Biol Chem"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-012-0916-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-012-0916-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-012-0916-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:54:28Z","timestamp":1559354068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-012-0916-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1007\/s11095-012-0916-0","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,8]]}}}